Differentiation: The specialized Bloom Structure design enables sustained drug absorption in the upper gastrointestinal tract, simplifying the dosing regimen and enhancing oral bioavailability.

Platform: 3D Microstructure for Gastric Retention

Differentiation: The specialized Bloom Structure design enables sustained drug absorption in the upper gastrointestinal tract, simplifying the dosing regimen and enhancing oral bioavailability.

Platform: 3D Microstructure for Gastric Retention

Differentiation: Allowing for precise targeting of drug release and delivery to the ileum ensures that the API reaches the ileal area of the intestine, where the disease originates and where API is most beneficial.

Platform: 3D Microstructure for Intestine Targeting

Differentiation: The dual-release tablet formulation, with an additional secondary drug release phase, holds promise for maintaining rapid sleep-onset efficacy while effectively preventing early-morning awakenings in insomnia patients and ameliorating comorbid symptoms such as sleep maintenance insomnia.

Platform: 3D Microstructure for Modified Release